Literature DB >> 16682492

Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany.

Kirsten Fluegge1, Anette Siedler, Beate Heinrich, Juergen Schulte-Moenting, Maria-Jantje Moennig, Dorothee B Bartels, Olaf Dammann, Ruediger von Kries, Reinhard Berner.   

Abstract

OBJECTIVE: Streptococcus agalactiae (group B Streptococcus) is an important cause of morbidity and mortality in newborn infants. So far, there have been no published data on the incidence, morbidity, and mortality of invasive neonatal group B Streptococcus infections in Germany.
METHODS: A prospective active surveillance study involving all of the pediatric hospitals, which reported their cases to the German Pediatric Surveillance Unit, and all of the microbiological laboratories serving pediatric hospitals, which reported their cases to the Laboratory Sentinel Group at Robert Koch Institute Berlin, was conducted between 2001 and 2003. Capture-recapture analysis was used to evaluate the completeness of reported neonatal invasive group B Streptococcus infections.
RESULTS: We collected and analyzed data from 347 and 360 infants with invasive group B Streptococcus infection during the first 3 months of life, as reported by pediatricians to the German Pediatric Surveillance Unit and microbiologists to the Robert Koch Institute Berlin, respectively. Using capture-recapture analysis, we calculated an incidence of 0.47 per 1000 live births. Nearly 60% of the infants suffered from early-onset disease, and 16% of these presented with meningitis. In contrast, 61.8% of infants with late-onset disease presented with meningitis. Prematurity was present in 22.4% of early-onset disease and 39.7% of late-onset disease cases, respectively. A high proportion of infants suffered from sequelae because of group B Streptococcus infection at the time of discharge from the hospital. Most common sequelae were hydrocephalus and cerebral seizure. Case fatality rate was 4.3%.
CONCLUSIONS: This study, which is the first to provide information on the current national incidence and morbidity of invasive group B Streptococcus infection in Germany, demonstrates remarkable country-specific variation in comparison with other European countries, which gather data in a similar fashion. Therefore, the importance of country-specific prevention guidelines has to be stressed.

Entities:  

Mesh:

Year:  2006        PMID: 16682492     DOI: 10.1542/peds.2005-2481

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  31 in total

1.  Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis.

Authors:  Anja Reiss; Johann S Braun; Katja Jäger; Dorette Freyer; Gregor Laube; Christoph Bührer; Ursula Felderhoff-Müser; Christine Stadelmann; Victor Nizet; Joerg R Weber
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

2.  Beyond counting cases: public health impacts of national Paediatric Surveillance Units.

Authors:  D Grenier; E J Elliott; Y Zurynski; R Rodrigues Pereira; M Preece; R Lynn; R von Kries; H Zimmermann; N P Dickson; D Virella
Journal:  Arch Dis Child       Date:  2006-12-11       Impact factor: 3.791

Review 3.  Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.

Authors:  J Rodriguez-Granger; J C Alvargonzalez; A Berardi; R Berner; M Kunze; M Hufnagel; P Melin; A Decheva; G Orefici; C Poyart; J Telford; A Efstratiou; M Killian; P Krizova; L Baldassarri; B Spellerberg; A Puertas; M Rosa-Fraile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

4.  Comparison of pre- and intrapartum screening of group B streptococci and adherence to screening guidelines: a cohort study.

Authors:  Mirjam Kunze; Katharina Zumstein; Filiz Markfeld-Erol; Roland Elling; Fabian Lander; Heinrich Prömpeler; Reinhard Berner; Markus Hufnagel
Journal:  Eur J Pediatr       Date:  2015-04-30       Impact factor: 3.183

5.  Chromosomally and Extrachromosomally Mediated High-Level Gentamicin Resistance in Streptococcus agalactiae.

Authors:  Parham Sendi; Martina Furitsch; Stefanie Mauerer; Carlos Florindo; Barbara C Kahl; Sarah Shabayek; Reinhard Berner; Barbara Spellerberg
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

6.  Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics.

Authors:  Capucine Didier; Marie-Pierre Streicher; Didier Chognot; Raphaèle Campagni; Albert Schnebelen; Jean Messer; Lionel Donato; Bruno Langer; Nicolas Meyer; Dominique Astruc; Pierre Kuhn
Journal:  Eur J Pediatr       Date:  2011-12-02       Impact factor: 3.183

7.  Immunochromatographic detection of the group B streptococcus antigen from enrichment cultures.

Authors:  Hidehito Matsui; Juri Kimura; Masato Higashide; Yoshio Takeuchi; Kuniyuki Okue; Longzhu Cui; Taiji Nakae; Keisuke Sunakawa; Hideaki Hanaki
Journal:  Clin Vaccine Immunol       Date:  2013-07-03

8.  Invasive group B streptococcus (GBS) disease in Norway 1996-2006.

Authors:  H Bergseng; M Rygg; L Bevanger; K Bergh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

9.  Whole-Genome Comparison Uncovers Genomic Mutations between Group B Streptococci Sampled from Infected Newborns and Their Mothers.

Authors:  Alexandre Almeida; Adrien Villain; Caroline Joubrel; Gérald Touak; Elisabeth Sauvage; Isabelle Rosinski-Chupin; Claire Poyart; Philippe Glaser
Journal:  J Bacteriol       Date:  2015-08-17       Impact factor: 3.490

10.  The causative organisms of bacterial meningitis in Korean children in 1996-2005.

Authors:  Hye Kyung Cho; Hyunju Lee; Jin Han Kang; Kwang Nam Kim; Dong Soo Kim; Yun Kyung Kim; Jung Soo Kim; Jong-Hyun Kim; Chang Hwi Kim; Hwang Min Kim; Su-Eun Park; Sung Hee Oh; Eun Hee Chung; Sung Ho Cha; Young Youn Choi; Jae Kyun Hur; Young Jin Hong; Hoan Jong Lee; Kyung-Hyo Kim
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.